Renovaro Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Renovaro Inc. and other ETFs, options, and stocks.About RENB
Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21.
CEODavid Weinstein
CEODavid Weinstein
Employees25
Employees25
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2011
Founded2011
Employees25
Employees25
RENB Key Statistics
Market cap56.60M
Market cap56.60M
Price-Earnings ratio-0.54
Price-Earnings ratio-0.54
Dividend yield—
Dividend yield—
Average volume801.15K
Average volume801.15K
High today$0.2638
High today$0.2638
Low today$0.2371
Low today$0.2371
Open price$0.26
Open price$0.26
Volume720.18K
Volume720.18K
52 Week high$2.10
52 Week high$2.10
52 Week low$0.2201
52 Week low$0.2201
People also own
Based on the portfolios of people who own RENB. This list is generated using Robinhood data, and it’s not a recommendation.